The effect of intravenous ferric-carboxymaltose on cardiac reverse remodeling following cardiac resynchronization therapy - The IRON CRT trial.
29 June 2021 (16:40 - 17:00)
Organised by:
Slides
About the speaker
Hospital Oost-Limburg (ZOL), Genk (Belgium)
2 More presentations in this session
Professor S. Solomon (Boston, US)
Access the full session
The Event
Heart Failure 2021
29 June 2021
16:40 CET
You may be interested in
Congress Presentation
Congress Presentation
